Expert consensus on establishment of standards for the performance evaluation of systems for whole blood C-reactive protein determination of Chinese children

doi:10.3969/j.issn.1673-8640.2021.012.001

Abstract

Abstract:

C-reactive protein（CRP）,which can be determined by serum as well as whole blood,has been traditionally utilized as a marker of infection. Many brands of whole blood CRP determination equipments have been widely used in medical institutions,especially in women's and children's hospitals. However,the standard for the performance evaluation of whole blood CRP determination system is not established. According to the data of 26 women's and children's hospitals,this consensus aims to provide the performance status of whole blood CRP determination system,and further put forward the performance evaluation requirements of whole blood CRP determination system in combination with clinical needs,biological variation and industry standards,so as to ensure the determination quality.

Key words: Children, Whole blood, C-reactive protein, Determination system, Performance evaluation

CLC Number:

R446.1

Clinical Diagnosis and Laboratory Medicine Branch of China Maternal and Child Health Association. Expert consensus on establishment of standards for the performance evaluation of systems for whole blood C-reactive protein determination of Chinese children[J]. Laboratory Medicine, 2021, 36(12): 1201-1205.

References 29

[1]	SIMON L, GAUVIN F, AMRE D K, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection:a systematic review and meta-analysis[J]. Clin Infect Dis, 2004, 39(2):206-217. DOI URL
[2]	ROBERTS W L, MOULTON L, LAW T C, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods:implications for clinical and epidemiological applications. Part 2[J]. Clin Chem, 2001, 47(3):418-425. DOI URL
[3]	Clinical and Laboratory Standards Institute. Procedures for the collection of diagnostic blood specimens by venipuncture[S]. H3-A6,CLSI, 2009.
[4]	尚红, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 4版. 北京: 人民卫生出版社, 2015.
[5]	中国医师协会检验医师分会儿科疾病检验医学专家委员会, 世界华人检验与病理医师协会. 中国末梢采血操作共识[J]. 中华医学杂志, 2018, 98(22):1752-1760.
[6]	中华人民共和国国家卫生和计划生育委员会. WS/T 420—2013 临床实验室对商品定量试剂盒分析性能的验证[S]. 北京:中华人民共和国国家卫生和计划生育委员会, 2013.
[7]	中国合格评定国家认可委员会. CNAS-GL037 临床化学定量检验程序性能验证指南[S]. 北京:中国合格评定国家认可委员会, 2019.
[8]	中华人民共和国卫生部. WS/T 406—2012 临床血液学检验常规项目分析质量要求[S]. 北京:中华人民共和国卫生部, 2012.
[9]	国家食品药品监督管理总局. YY/T 0654—2017 全自动生化分析仪[S]. 北京:国家食品药品监督管理总局, 2017.
[10]	Clinical and Laboratory Standards Institute. Interference testing in clinical chemistry[S]. EP07-A3,CLSI, 2018.
[11]	Clinical and Laboratory Standards Institute. Preliminary evaluation of quantitative clinical laboratory measurement procedures[S]. EP10-A3,CLSI, 2014.
[12]	中华医学会检验医学分会临床化学学组. 生化分析仪携带污染的分析评估及处理方法专家共识[J]. 中华检验医学杂志, 2020, 43(7):712-717.
[13]	Clinical and Laboratory Standards Institute. Validation,verification,and quality assurance of automated hematology analyzers[S]. H26-A2,CLSI, 2013.
[14]	国家食品药品监督管理总局. YY/T 1513—2017 C反应蛋白测定试剂盒[S]. 北京:国家食品药品监督管理总局, 2017.
[15]	中国合格评定国家认可委员会. CNAS-CL02-A003 医学实验室质量和能力认可准则在临床化学检验领域的应用说明[S]. 北京:中国合格评定国家认可委员会, 2018.
[16]	中华人民共和国国家卫生和计划生育委员会. WS/T 492—2016 临床检验定量测定项目精密度与正确度性能验证[S]. 北京:中华人民共和国国家卫生和计划生育委员会, 2016.
[17]	Clinical and Laboratory Standards Institute. User verification of performance for precision and trueness[S]. EP15-A2,CLSI, 2008.
[18]	Clinical and Laboratory Standards Institute. Evaluation of precision of quantitative measurement procedures[S]. EP05-A3,CLSI, 2014.
[19]	中华人民共和国国家卫生和计划生育委员会. WS/T 408—2012 临床化学设备线性评价指南[S]. 北京:中华人民共和国国家卫生和计划生育委员会, 2012.
[20]	Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative measurement procedures:a statistical approach[S]. EP06-A,CLSI, 2003.
[21]	International Council for Standardization in Haematology. Guidelines for the evaluation of blood cell analysers including those used for differential leucocyte and reticulocyte counting[S]. ICSH, 2014.
[22]	隆维东, 李坚, 刘万斌. 不同红细胞压积对全血CRP测定的影响及校正措施[J]. 国际检验医学杂志, 2012, 33(1):107-109.
[23]	马继荣, 周景艺, 顾怡, 等. HCT值实时修正全血CRP测定结果的评估[J]. 检验医学, 2018, 33(11):983-986.
[24]	TUGIRIMANA P L, HOLDERBEKE A L, KINT J A, et al. A new turbidimetric method for assaying C-reactive protein based on phosphocholine interaction[J]. Clin Chem Lab Med, 2009, 47(11):1417-1422.
[25]	DE HAENE H, TAES Y, CHRISTOPHE A, et al. Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism[J]. Clin Chem Lab Med, 2006, 44(2):220-222.
[26]	SUNG H J, KIM J H, PARK R, et al. Evaluation of Denka-Seiken turbidimetric high-sensitivity C-reactive protein assay[J]. Clin Chem Lab Med, 2002, 40(8):840-845.
[27]	VEROUGSTRAETE N, VERBEKE F, DELANGHE J R. Exogenous triglycerides interfere with a point of care CRP assay:a pre-analytical caveat[J]. Clin Chem Lab Med, 2020, 59(4):e141-e143. DOI URL
[28]	中华人民共和国国家卫生健康委员会. WS/T 404.4—2018 临床常用生化检验项目参考区间第4部分:血清总胆红素、直接胆红素[S]. 北京:中华人民共和国国家卫生健康委员会, 2018.
[29]	Clinical and Laboratory Standards Institute. Measurement procedure comparison and bias estimation using patient samples[S]. EP09-A3,CLSI, 2013.